SALVIONI LUCIA

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES [10.1021/acsami.5c06626]. Dettaglio

Sinesi, G., Salvioni, L., Ronchi, E., Barbuzzi, E., Prosperi, D., Colombo, M., et al. (2025). Exploring Bovine Serum Albumin (BSA) as a Facile Substrate for Testing of Osmolytes as Cosmetic Ingredients. MOLECULES, 30(3) [10.3390/molecules30030664]. Dettaglio

Testa, F., Salvioni, L., Giustra, M., Ostroman, I., Ferrari, B., Duncan, C., et al. (2024). A new approach for direct visualization of unlabeled lipid nanoparticles for intracellular pathway analysis. Intervento presentato a: European Microscopy Congress 2024 - 25 - 30 August 2024, Copenaghen, Denmark. Dettaglio

Ochoa, E., Morelli, L., Salvioni, L., Giustra, M., De Santes, B., Spena, F., et al. (2024). Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 194(January 2024), 85-94 [10.1016/j.ejpb.2023.11.023]. Dettaglio

Viale, F., Ciprandi, M., Leoni, L., Sierri, G., Renda, A., Barbugian, F., et al. (2024). Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 96(June 2024) [10.1016/j.jddst.2024.105672]. Dettaglio